National Diabetes Month Highlights Importance of Point-of-Care Testing

​November is National Diabetes Month in the United States and throughout the month, our social media channels will be focused on providing information about the management and diagnosis of both diabetes and prediabetes.

So, what is diabetes? Put simply, it’s a disease that prohibits one’s body from converting the glucose from food into energy. It occurs in the pancreas but can impact nearly all of the vital organs.

According to the Centers for Disease Control and Prevention, one in 10 Americans has diabetes. Perhaps even more startling, many at risk of becoming diabetics don’t even know it. A recent study published in JAMA finds that only 12 percent of those with prediabetes know that they have it and that half of all adults in the U.S. are either prediabetic or diabetic.

An effective way of managing both diabetes and prediabetes is through point-of-care testing. With quick lipid, glucose and A1C measurements, physicians are able to quickly interpret results and use office-time to have a meaningful conversation about effective disease management methods.

Moreover, point-of-care testing also increases the rate of diagnosis by eliminating the risk of patient’s failing to complete lab testing or not coming back to their physician’s office for follow-up appointments. A 2011 study by Kaiser found that the average turnaround time for lab results is 25-30 days; a delay in diagnosis that can have a negative impact on diabetics and prediabetics.

At PTS Diagnostics, we understand that diabetes and prediabetes diagnosis can be overwhelming, so we’ve compiled online resources for disease management and support.

We encourage everyone to ask their primary care physician about their diabetes risk and the benefits of point-of-care testing. To learn more about our specialized point-of-care solutions and our commitment to helping diabetics, connect with PTS.

MACRA's Impact on Point-of-Care

Rising medical costs and the evolving complexity of healthcare delivery has caused some providers and patients to think outside of the box when it comes to cost-effective coverage.

Healthcare’s standard Fee-For-Service (FFS) model compensates physicians, hospitals, clinics, etc. strictly based on the quantity and complexity of the services they provide.

The Medicare Access and CHIP Reauthorization Act (MACRA) differs in that it rewards healthcare providers through Merit Based Incentives (MIPS) and Advanced Payment Models (APMs) that give financial benefits based on the quality and efficiency of their care.


 Point-of-care medical devices align seamlessly into this new age healthcare model by improving the turnaround time for test results when compared to outside labs; revolutionizing the way that providers interact with patients.

Since patient care providers can interpret glucose, A1C and cholesterol levels in just minutes, they’re often able to develop a treatment plan immediately, allowing for more meaningful dialogues with their patients. This can help improve a patient’s quality of life by allowing them to more quickly make informed decisions about diet, exercise and lifestyle.

Healthcare organizations throughout the United States are beginning to take notice of the importance of efficiency. According to the 2016 Health Industry Distributors Association Patient Satisfaction Survey, 52 percent of acute care providers are actively planning to decrease the turnaround time for medical tests within the next two years.

When disease management moves as fast as the rest of our lives, it can become a part of our lives. For more information about point-of-care technology, learn more about PTS Diagnostics.

Jeff Stebbins | Head of Payer Strategy and Marketing

The Importance of Proficiency Testing

​It’s rewarding to work for a comprehensive point-of-care diagnostics company that designs and manufactures products used for testing cardiovascular heart disease, diabetes and more. Anyone who’s ever been impacted by these diseases knows how important fast and accurate test results are. Accurate results aid in physician decisions and in many cases can provide peace of mind for those undergoing routine laboratory testing.

Healthcare providers in 135 countries trust the CardioChek® and A1CNOW® to help in diagnosing and treating patients at the point-of-care. Ensuring that these analyzers perform and produce quality results is a top priority. One of the most important aspects to my role as Director of Clinical Laboratory Medicine is to give our customers confidence in our analyzers and results.

​Verifying that our technology works correctly can identify potential testing issues. Proficiency testing is a part of a quality assurance program that reassures the accurate performance of our products. It’s an effective tool because it not only tests our analyzers, but the testing process itself. Even though it’s not required in most states, we encourage all of our customers to pursue proficiency testing through American Proficiency Institute. This third-party proficiency testing program provides an extra boost of confidence in PTS Diagnostic’s analyzers and their results to patients and physicians.

All of our analyzers are eligible for proficiency testing. The biggest takeaway that I want to leave with decision makers at medical facilities is that proficiency testing is just one more arrow in your quiver. It gives confidence in the ability of a test system to provide quality results and can help to proactively identify any potential issues that could be seen down the road. This is why I believe proficiency testing is an important quality assurance tool for our A1CNOW+ and CardioChek systems.

I encourage anyone with questions about beginning this process to connect with us to learn more about PTS Diagnostics

Carrie Szablowski | Director of Clinical Laboratory Medicine